Market revenue in 2020 | USD 2,006.1 million |
Market revenue in 2028 | USD 3,607.7 million |
Growth rate | 7.6% (CAGR from 2020 to 2028) |
Largest segment | External beam radiationtherapy |
Fastest growing segment | Internal Beam Radiation Therapy |
Historical data covered | 2017 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
External beam radiationtherapy was the largest segment with a revenue share of 68.41% in 2020. Horizon Databook has segmented the Europe radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
Europe is a major contributor to revenue of global radiation oncology market. Presence of sophisticated technology, well-established research infrastructure, and rise in government initiatives are some of the major factors responsible for the growth of this market in Europe.
In June 2017, The European government spent GBP 250 million to develop two NHS centers providing proton beam therapy at The Christie Hospital, Manchester. Rising awareness among cancer patients about radiation oncology treatment is expected to boost the market.
For instance, Gustave Roussy the premier European Cancer Center provides an integrated approach to patient care, education, and research to benefit patients with best quality treatment such as chemotherapy and radiation therapy.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account